BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36471329)

  • 1. Interruption of the long non-coding RNA HOTAIR signaling axis ameliorates chemotherapy-induced cachexia in bladder cancer.
    Hu CY; Su BH; Lee YC; Wang CT; Yang ML; Shen WT; Fu JT; Chen SY; Huang WY; Ou CH; Tsai YS; Kuo FC; Shiau AL; Shieh GS; Wu CL
    J Biomed Sci; 2022 Dec; 29(1):104. PubMed ID: 36471329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas.
    Wang Y; Yi K; Liu X; Tan Y; Jin W; Li Y; Zhou J; Wang H; Kang C
    Front Immunol; 2021; 12():785463. PubMed ID: 34887871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.
    Özeş AR; Miller DF; Özeş ON; Fang F; Liu Y; Matei D; Huang T; Nephew KP
    Oncogene; 2016 Oct; 35(41):5350-5361. PubMed ID: 27041570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-noncoding RNA Atrolnc-1 promotes muscle wasting in mice with chronic kidney disease.
    Sun L; Si M; Liu X; Choi JM; Wang Y; Thomas SS; Peng H; Hu Z
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):962-974. PubMed ID: 30043444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
    Chen MC; Hsu WL; Hwang PA; Chen YL; Chou TC
    Oncotarget; 2016 Aug; 7(32):51608-51618. PubMed ID: 27323407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTAIR regulates lipopolysaccharide-induced inflammatory response in hepatocytes.
    Zhang J; Chen M; Zhai Y; Fu Y
    J Cell Physiol; 2020 May; 235(5):4247-4255. PubMed ID: 31621909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOTAIR regulates the stemness of breast cancer cells via activation of the NF-κB signaling pathway.
    Wang J; Liu X; Li P; Wang J; Shu Y; Zhong X; Gao Z; Yang J; Jiang Y; Zhou X; Yang G
    J Biol Chem; 2022 Dec; 298(12):102630. PubMed ID: 36273585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer.
    Özeş AR; Wang Y; Zong X; Fang F; Pilrose J; Nephew KP
    Sci Rep; 2017 Apr; 7(1):894. PubMed ID: 28420874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOTAIR alleviates rheumatoid arthritis by targeting miR-138 and inactivating NF-κB pathway.
    Zhang HJ; Wei QF; Wang SJ; Zhang HJ; Zhang XY; Geng Q; Cui YH; Wang XH
    Int Immunopharmacol; 2017 Sep; 50():283-290. PubMed ID: 28732288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lncRNA HOTAIR on proliferation and apoptosis of myeloma cells through NF-κB pathway.
    Zhu BZ; Lin L
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10042-10048. PubMed ID: 31799674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway.
    Ma Y; Zhou G; Li M; Hu D; Zhang L; Liu P; Lin K
    Neurochem Int; 2018 Sep; 118():233-241. PubMed ID: 29572052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway.
    Wu H; Liu J; Li W; Liu G; Li Z
    Biochem Biophys Res Commun; 2016 Feb; 471(1):240-6. PubMed ID: 26806307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOX transcript antisense RNA is elevated in gastric carcinogenesis and regulated by the NF-κB pathway.
    Zhang Z; Fan B; Liu F; Song N; Peng Y; Ma W; Ma R; Dong T; Liu S
    J Cell Biochem; 2019 Jun; 120(6):10548-10555. PubMed ID: 30635945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicities.
    Gil da Costa RM; Levesque C; Bianchi-Frias D; Chatterjee P; Lam HM; Santos C; Coleman IM; Ferreirinha P; Vilanova M; Pinto da Cunha N; Carvalho H; Moreira-Pais A; Faustino-Rocha A; Neto T; Batista da Costa J; Wright JL; Ferreira R; Oliveira PA; Mendes J; Bastos MMSM; Colaço B; Lopes C; Black PC; Sweeney CJ; Nelson PS
    Mol Oncol; 2023 Dec; 17(12):2709-2727. PubMed ID: 37533407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
    Tanaka K; Babic I; Nathanson D; Akhavan D; Guo D; Gini B; Dang J; Zhu S; Yang H; De Jesus J; Amzajerdi AN; Zhang Y; Dibble CC; Dan H; Rinkenbaugh A; Yong WH; Vinters HV; Gera JF; Cavenee WK; Cloughesy TF; Manning BD; Baldwin AS; Mischel PS
    Cancer Discov; 2011 Nov; 1(6):524-38. PubMed ID: 22145100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.